Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Sadif Analytics (Premium)

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Immuno-Biological Laboratories Co Ltd to Acquire Shares in Japan-based Company

Tuesday, 17 Sep 2013 02:30am EDT 

Immuno-Biological Laboratories Co Ltd announced that it will acquire 1,600 shares in a Japan-based company, which is engaged in sale of Neosilk-human collagen as well as production and sale of cosmetics, for JPY 50,000 per share or JPY 80 million in total. As a result, the Company will hold a 79.6% stake (1,720 shares) in the Japan-based company up from 21.4% stake (120 shares) and will begin cosmetics business through the new subsidiary, effective October 1, 2013. 

Company Quote

-1.0 -0.10%
27 Aug 2014